Big Pharma Can’t Figure Out How To Cash In On ‘Long COVID’
Authors:mmDYLAN HOUSMANHEALTHCARE REPORTER July 11, 2022 Major pharmaceutical companies are struggling to develop treatments for “long COVID” because it’s been nearly impossible to nail down what exactly the ailment actually is, according to a new report from The Wall Street Journal. The rapid development of COVID-19 vaccines and antiviral treatments resulted in record-breaking profits for companies like […]